Valeo Pharma Inc.
VPHIF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $5,123 | $4,666 | $28,555 | $13,683 |
| - Cash | $7,125 | $6,890 | $9,585 | $7,502 |
| + Debt | $70,083 | $68,182 | $66,355 | $65,169 |
| Enterprise Value | $68,081 | $65,958 | $85,325 | $71,350 |
| Revenue | $12,601 | $14,129 | $13,539 | $13,108 |
| % Growth | -10.8% | 4.4% | 3.3% | – |
| Gross Profit | $3,434 | $2,747 | $2,102 | $632 |
| % Margin | 27.3% | 19.4% | 15.5% | 4.8% |
| EBITDA | -$3,679 | -$3,331 | -$4,305 | -$4,865 |
| % Margin | -29.2% | -23.6% | -31.8% | -37.1% |
| Net Income | -$8,192 | -$7,811 | -$6,872 | -$9,245 |
| % Margin | -65% | -55.3% | -50.8% | -70.5% |
| EPS Diluted | -0.083 | -0.079 | -0.08 | -0.098 |
| % Growth | -4.8% | 0.8% | 18.8% | – |
| Operating Cash Flow | $451 | -$3,531 | $1,471 | -$2,670 |
| Capital Expenditures | $0 | -$40 | -$50 | -$5,029 |
| Free Cash Flow | $451 | -$3,571 | $1,421 | -$7,699 |